GREM2
Gremlin-2
Also known as: CKTSF1B2, DAND3, FLJ21195, GREM2_HUMAN, Prdc
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H772
- Gene
- GREM2
- Ensembl
- ENSG00000180875
- Chromosome
- 1
- Canonical length
- 168 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the BMP (bone morphogenic protein) antagonist family. Like BMPs, BMP antagonists contain cystine knots and typically form homo- and heterodimers. The CAN (cerberus and dan) subfamily of BMP antagonists, to which this gene belongs, is characterized by a C-terminal cystine knot with an eight-membered ring. The antagonistic effect of the secreted glycosylated protein encoded by this gene is likely due to its direct binding to BMP proteins. As an antagonist of BMP, this gene may play a role in regulating organogenesis, body patterning, and tissue differentiation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
168 residues, UniProt reviewed canonical sequence.
>Q9H772|GREM2
1 MFWKLSLSLF LVAVLVKVAE ARKNRPAGAI PSPYKDGSSN NSERWQHQIK EVLASSQEAL
61 VVTERKYLKS DWCKTQPLRQ TVSEEGCRSR TILNRFCYGQ CNSFYIPRHV KKEEESFQSC
121 AFCKPQRVTS VLVELECPGL DPPFRLKKIQ KVKQCRCMSV NLSDSDKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GREM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- gallbladder: 29 nTPM
- liver: 25 nTPM
- parathyroid gland: 22 nTPM
- rectum: 19 nTPM
- esophagus: 16 nTPM
- colon: 16 nTPM
Single-cell type
- syncytiotrophoblasts: 886 nCPM
- breast lactating cells: 565 nCPM
- thymic myoid cells: 214 nCPM
- somatotrophs: 213 nCPM
- salivary acinar cells: 173 nCPM
- retinal bipolar cells: 104 nCPM
Immune cell
- memory CD4 T-cell: 0.5 nTPM
- MAIT T-cell: 0.4 nTPM
- memory CD8 T-cell: 0.2 nTPM
- naive CD4 T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- cerebral cortex: 20 nTPM
- basal ganglia: 11 nTPM
- thalamus: 11 nTPM
- medulla oblongata: 9.7 nTPM
- hypothalamus: 9.6 nTPM
- white matter: 9.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GREM2.
Disease | AllUniProt
Conditions GREM2 is implicated in, by any mechanism.
- Tooth agenesis, selective, 9 (STHAG9) MIM:617275
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 25 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Tooth agenesis, selective, 9
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 1.23
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytokine-mediated signaling pathway
- determination of dorsal identity
- embryonic body morphogenesis
- sequestering of BMP from receptor via BMP binding
- regulation of cytokine activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GREM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GREM2 as an antibody target. Whether an autoantibody or antibody against GREM2 could matter depends on whether native GREM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GREM2 is annotated as secreted, so native GREM2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label GREM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...